SCHEMBL26103340

SCHEMBL26103340

C=CC(=O)N1CCC(c2nccnc2Oc2cnc(C(F)(F)F)nc2)CC1

nearest known ligand 0.42

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ TEAD1 P28347 4/20 0.39
▸ TEAD3 Q99594 1/20 0.39
▸ PDE10A Q9Y233 3/20 0.38
▸ TRPV1 Q8NER1 1/20 0.36
▸ BTK Q06187 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30591679 1.00 TEAD1 (0.39) TEAD1TEAD3PDE10ATRPV1BTK
SCHEMBL26108741 0.87 SCN9A (0.42) TEAD1TEAD3PDE10A
SCHEMBL30591799 0.87 SCN9A (0.42) TEAD1TEAD3PDE10A
SCHEMBL30591841 0.85 PDE10A (0.38) PDE10ATRPV1
SCHEMBL26107347 0.85 PDE10A (0.42) TEAD1TEAD3PDE10ABTK
SCHEMBL30591828 0.82 TRPV1 (0.39) PDE10ATRPV1BTK
SCHEMBL26109229 0.82 TRPV1 (0.39) PDE10ATRPV1BTK
SCHEMBL30591918 0.81 LIPE (0.48) TEAD1TRPV1BTK
SCHEMBL26108191 0.78 PDE10A (0.36) PDE10A
SCHEMBL26105526 0.78 PDE10A (0.33) PDE10ATRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250206722-A1 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS THE SCRIPPS RESEARCH INSTITUTE 2025-06-26 — — US claimed
WO-2023183768-A2 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS THE SCRIPPS RESEARCH INSTITUTE (US) 2023-09-28 — — WO claimed
US-20250206722-A1 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS THE SCRIPPS RESEARCH INSTITUTE 2025-06-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250206722-A1 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS YAP1, TEAD1, TEAD2 TEAD1 2/4885TEAD3 4/4885PDE10A 3863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback